Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Whole-body MRI and circulating biomarkers in spondyloarthritis patients treated with adalimumab (ASIM)
2009-014348-12Phase 4Completed
- Sponsor
- Mikkel Østergaard
- Start
- Sep 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of adalimumab in spondyloarthritis (SpA), sponsored by Mikkel Østergaard. Primary endpoint: Primary BASDAI response at week 24. Started Sep 2009; status: completed.
02
Drugs
03
Conditions
spondyloarthritis (SpA)
Beyond the preview
Go deeper on 2009-014348-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014348-12.